PinnyPeptide

Cardiogen vs Vilon

Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.

Peptide A

Cardiogen

Bioregulators

Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium.

Peptide B

Vilon

Bioregulators

Khavinson Lys-Glu dipeptide — immunomodulator with documented life-extension activity in mice.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Typical vial

20 mg

Typical dose

1,000-5,000 mcg

Half-life

Short (minutes); biological effect persists via gene-expression modulation

FDA status

Not FDA approved.

Cardiogen effects

  • Reported improvement in myocardial contractility (Russian observational)
  • Possible reduction in age-related cardiac decline
  • Improved exercise tolerance in elderly CAD patients
  • Modulation of cardiac remodeling processes
  • Anti-inflammatory effects in cardiac tissue

Vilon effects

  • Reported immunomodulatory effects
  • Life-extension and tumor-reduction in mouse studies (Khavinson group)
  • Possible telomere-related activity
  • Support of T-cell function in elderly populations
  • Modulation of immune gene expression

Cardiogen side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Should not substitute for proven cardiac therapies

Vilon side effects

  • Generally well-tolerated in Russian clinical use
  • Mild injection-site reactions
  • Limited Western safety validation
  • Caution in active autoimmune disease

Cardiogen dosing ranges

Cardiac function support

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Vilon dosing ranges

Immune support / anti-aging research

1-5 mg · Once daily (SubQ) or sublingual · 10-20 day cycles, repeated 2-3 times per year

Full Cardiogen guide → Full Vilon guide →

Cardiogen vs Vilon — common questions

What is the difference between Cardiogen and Vilon?

Cardiogen: Khavinson short peptide bioregulator targeting cardiac muscle and vascular endothelium. Typical dose 1,000-5,000 mcg. Vilon: Khavinson Lys-Glu dipeptide — immunomodulator with documented life-extension activity in mice. Typical dose 1,000-5,000 mcg. Both fall under the Bioregulators category.

Can you stack Cardiogen and Vilon?

Stacking Cardiogen with Vilon is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.

Which is dosed more frequently, Cardiogen or Vilon?

Cardiogen is typically dosed: Once daily (SubQ) or sublingual for Cardiac function support. Vilon is typically dosed: Once daily (SubQ) or sublingual for Immune support / anti-aging research.

Are Cardiogen and Vilon FDA approved?

Cardiogen: Not FDA approved. Vilon: Not FDA approved.

Related peptide comparisons

bronchogen vs cardiogencardiogen vs cartalaxcardiogen vs cortagencardiogen vs crystagencardiogen vs ovagencardiogen vs pancragen

Tracking either of these?

Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.

Get Started Free